Webinar: ACR/CHEST ILD Guidelines in Practice| Video: All the Lonely People

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

PAC Progress and Challenges

David Holzman  |  

After three years, RheumPAC has a solid start, and more work ahead of it

Members, Submitters Share Thoughts on ACR Journals

Robert I. Fox, MD, PhD, and Carla M. Fox, RN  |  

In an online survey conducted in the spring of 2009, the ACR collected information on journal readership patterns, satisfaction, and content interests. The survey was sent to a sample of ACR and ARHP members who had not submitted manuscripts to Arthritis & Rheumatism (A&R) or Arthritis Care & Research (AC&R) within a recent 12-month period. It was also sent, with additional questions regarding submission and review, to all members and nonmembers who had submitted at least one manuscript to either journal during the 12-month period. Because of the international scope and reputation of the ACR journals, along with the fact that most members are in clinical practice and do not generally conduct and publish research, 63% of the submitters to the journals are not members of the ACR or ARHP. The ACR journals have long been viewed as the place where both members and nonmembers seek to publish their high-quality work.

RheumPAC Supports Two Candidates Who Support Rheumatology

  |  

RheumPAC, the ACR’s political action committee (PAC), ensures that the ACR is involved in healthcare reform discussions. RheumPAC representatives have been busy attending fundraisers and educating key congressional members on the ACR’s legislative priorities.

Experiencing EULAR: An ARHP Perspective

Pamela J. Degotardi, PhD  |  

I’m writing this column in my hotel room in rainy, somewhat chilly, Copenhagen. So much for the summer dresses that I packed in preparation for attending this European League Against Rheumatism (EULAR) meeting. Instead it’s been all about layering and trying to stay dry, dodging puddles, and struggling with blown-out umbrellas. The rain has impeded any desire to explore Tivoli gardens, but it hasn’t dampened the friendliness and welcome of our European counterparts in EULAR’s Allied Health Professionals (AHP) standing committee.

Pharmaceutical Tourism

Bruce N. Cronstein, MD  |  

Could trade agreements and not bulky legislation be the key to cheaper drugs?

The Canes of York

David S. Pisetsky, MD, PhD  |  

What can a walking stick tell us about U.S. healthcare?